Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
Feb 13  •  04:00PM ET
85.92
Dollar change
+0.56
Percentage change
0.66
%
IndexRUT P/E35.97 EPS (ttm)2.39 Insider Own1.88% Shs Outstand35.04M Perf Week-0.61%
Market Cap3.01B Forward P/E13.65 EPS next Y6.30 Insider Trans1.01% Shs Float34.38M Perf Month1.44%
Enterprise Value4.26B PEG1.52 EPS next Q1.70 Inst Own106.41% Short Float8.83% Perf Quarter23.61%
Income86.86M P/S1.65 EPS this Y19.58% Inst Trans-5.27% Short Ratio4.66 Perf Half Y-19.53%
Sales1.83B P/B1.72 EPS next Y-0.66% ROA2.66% Short Interest3.04M Perf YTD9.55%
Book/sh49.83 P/C51.08 EPS next 5Y8.95% ROE5.18% 52W High144.76 -40.65% Perf Year-38.04%
Cash/sh1.68 P/FCF24.81 EPS past 3/5Y6.58% 4.13% ROIC2.85% 52W Low62.00 38.58% Perf 3Y19.12%
Dividend Est.- EV/EBITDA12.26 Sales past 3/5Y12.07% 6.43% Gross Margin23.82% Volatility2.69% 2.44% Perf 5Y5.73%
Dividend TTM- EV/Sales2.33 EPS Y/Y TTM-26.32% Oper. Margin12.24% ATR (14)2.17 Perf 10Y177.33%
Dividend Ex-Date- Quick Ratio2.45 Sales Y/Y TTM7.81% Profit Margin4.75% RSI (14)56.33 Recom2.42
Dividend Gr. 3/5Y- - Current Ratio3.71 EPS Q/Q12.53% SMA20-0.08% Beta0.74 Target Price85.57
Payout0.00% Debt/Eq0.75 Sales Q/Q8.38% SMA506.40% Rel Volume1.43 Prev Close85.36
Employees11000 LT Debt/Eq0.75 EarningsFeb 19 BMO SMA200-12.57% Avg Volume652.37K Price85.92
IPOSep 29, 2000 Option/ShortYes / Yes EPS/Sales Surpr.6.07% 0.27% Trades Volume929,684 Change0.66%
Date Action Analyst Rating Change Price Target Change
Oct-24-25Downgrade Wells Fargo Overweight → Equal Weight $80
Oct-24-25Downgrade The Benchmark Company Buy → Hold
Oct-24-25Downgrade Citigroup Buy → Neutral $77
Oct-24-25Downgrade BofA Securities Buy → Neutral $87
Oct-24-25Downgrade Argus Buy → Hold
May-22-25Upgrade Citigroup Neutral → Buy $140
Mar-28-25Initiated Raymond James Outperform $145
Feb-21-25Downgrade Oppenheimer Outperform → Perform
Dec-03-24Resumed Wells Fargo Overweight $160
Jul-16-24Initiated Oppenheimer Outperform $135
Feb-12-26 05:30PM
Jan-28-26 09:00AM
08:00AM
Jan-23-26 07:29AM
Jan-22-26 11:08AM
08:00AM Loading…
08:00AM
Jan-18-26 11:07PM
Jan-16-26 02:52AM
Jan-14-26 08:00AM
02:43AM
Jan-13-26 09:06AM
Jan-09-26 09:00AM
Jan-06-26 09:00AM
Dec-29-25 01:34AM
Dec-28-25 11:34PM
07:00AM Loading…
Dec-22-25 07:00AM
Dec-19-25 09:00AM
Dec-17-25 05:00PM
Nov-18-25 08:00AM
Nov-10-25 04:27AM
Nov-04-25 08:00AM
Oct-30-25 01:36AM
Oct-27-25 09:45AM
Oct-25-25 08:30AM
Oct-24-25 01:53PM
09:56AM
09:34AM
09:18AM
09:00AM
08:00AM
03:50PM Loading…
Oct-23-25 03:50PM
03:08PM
11:29AM
09:30AM
09:20AM
09:15AM
08:34AM
08:17AM
08:00AM
Oct-21-25 11:07PM
Oct-13-25 11:40AM
05:34AM
Oct-10-25 11:04AM
12:02AM
Oct-07-25 12:00PM
09:40AM
Oct-03-25 09:40AM
Sep-26-25 11:40AM
Sep-25-25 08:00AM
Sep-24-25 11:31PM
Sep-19-25 09:40AM
Sep-18-25 10:42AM
Sep-15-25 12:35AM
Sep-10-25 11:40AM
Sep-02-25 04:26PM
10:36AM
09:55AM
Sep-01-25 09:40AM
Aug-22-25 01:56PM
05:04AM
Aug-21-25 10:39AM
Aug-19-25 11:40AM
Aug-15-25 09:40AM
Aug-12-25 08:00AM
Aug-04-25 09:37AM
Jul-29-25 11:40AM
09:40AM
Jul-25-25 12:23PM
07:02AM
Jul-24-25 01:05PM
09:15AM
08:32AM
08:00AM
Jul-23-25 09:36AM
Jul-22-25 11:12PM
Jul-21-25 08:38AM
Jul-20-25 11:34PM
Jul-17-25 11:33AM
Jul-11-25 11:40AM
09:57AM
Jul-10-25 04:52PM
12:09PM
Jul-09-25 12:04PM
11:57AM
Jul-07-25 11:51AM
Jul-04-25 09:50AM
09:45AM
Jul-02-25 04:05PM
10:03AM
08:21AM
Jul-01-25 09:40AM
Jun-30-25 08:30AM
Jun-26-25 10:55AM
09:05AM
08:23AM
08:00AM
Jun-25-25 11:40AM
10:03AM
Jun-24-25 10:43AM
Jun-23-25 11:20AM
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. The firm has the following product lines: Cardio and Vascular, Cardiac Rhythm Management and Neuromodulation, and Other Markets. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAILEY PAMELA GDirectorJan 02 '26Option Exercise48.432,883139,62456,052Jan 05 07:29 PM
MAXWELL MARTIN CDirectorDec 12 '25Option Exercise48.432,883139,62425,053Dec 16 07:20 PM
Harris John AEVP, Global Ops and ManufacturNov 12 '25Buy70.001,650115,5006,066Nov 13 04:18 PM
Thomas Tommy PVP, Corporate ControllerNov 11 '25Sale70.1588462,0133,596Nov 13 08:12 AM
Smith DironEVP, Chief Financial OfficerNov 07 '25Buy67.191,11674,9677,698Nov 10 08:19 AM
Capps Cheryl CDirectorNov 06 '25Buy66.701,600106,72011,702Nov 10 08:16 AM
Khales PaymanPresident & CEOOct 30 '25Buy64.943,127203,06722,865Oct 30 04:05 PM
Dziedzic Joseph WPresident & CEOJun 11 '25Option Exercise0.0036,202059,202Jun 13 06:09 PM
MAXWELL MARTIN CDirectorJun 05 '25Option Exercise49.908,720435,12830,890Jun 06 06:49 PM
MAXWELL MARTIN CDirectorJun 05 '25Sale120.568,7201,051,27922,170Jun 06 06:49 PM
Spence Donald JDirectorJun 04 '25Option Exercise19.4314,739286,37933,520Jun 06 06:09 PM
Spence Donald JDirectorJun 04 '25Sale120.3814,7391,774,34018,781Jun 06 06:09 PM
MAXWELL MARTIN CDirectorJun 05 '25Proposed Sale120.678,7201,052,242Jun 05 03:42 PM
Spence Donald JDirectorJun 04 '25Proposed Sale120.3814,7391,774,339Jun 04 04:25 PM
Marshall McAlister C IIFormer OfficerJun 03 '25Proposed Sale120.006,830819,600Jun 03 02:45 PM
Dziedzic Joseph WPresident & CEOMay 01 '25Option Exercise43.7271,3843,120,552385,975May 02 07:52 PM
Dziedzic Joseph WPresident & CEOMay 01 '25Sale123.17338,97541,751,43347,000May 02 07:52 PM
Joseph DziedzicOfficerMay 01 '25Proposed Sale126.31267,59133,799,419May 01 06:23 PM
Dziedzic Joseph WOfficerMay 01 '25Proposed Sale125.8771,3848,984,922May 01 04:16 PM
Dziedzic Joseph WPresident & CEOMar 11 '25Option Exercise0.0036,2020327,986Mar 13 08:04 PM
Last Close
Feb 13  •  04:00PM ET
13.38
Dollar change
+0.11
Percentage change
0.83
%
OFIX Orthofix Medical Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-3.04 Insider Own2.05% Shs Outstand39.52M Perf Week4.53%
Market Cap529.84M Forward P/E- EPS next Y-1.60 Insider Trans-3.13% Shs Float38.79M Perf Month-6.56%
Enterprise Value668.37M PEG- EPS next Q-0.19 Inst Own88.13% Short Float2.60% Perf Quarter-12.55%
Income-119.12M P/S0.65 EPS this Y31.52% Inst Trans-0.76% Short Ratio4.66 Perf Half Y-4.56%
Sales818.06M P/B1.19 EPS next Y28.98% ROA-14.01% Short Interest1.01M Perf YTD-11.74%
Book/sh11.20 P/C8.03 EPS next 5Y34.67% ROE-24.60% 52W High20.48 -34.67% Perf Year-26.97%
Cash/sh1.67 P/FCF- EPS past 3/5Y-19.24% -17.02% ROIC-18.53% 52W Low10.24 30.66% Perf 3Y-37.77%
Dividend Est.- EV/EBITDA- Sales past 3/5Y19.84% 11.69% Gross Margin64.64% Volatility4.17% 3.54% Perf 5Y-69.02%
Dividend TTM- EV/Sales0.82 EPS Y/Y TTM3.26% Oper. Margin-11.55% ATR (14)0.51 Perf 10Y-63.72%
Dividend Ex-Date- Quick Ratio1.38 Sales Y/Y TTM4.31% Profit Margin-14.56% RSI (14)44.07 Recom1.80
Dividend Gr. 3/5Y- - Current Ratio2.47 EPS Q/Q19.45% SMA200.53% Beta0.75 Target Price19.50
Payout- Debt/Eq0.46 Sales Q/Q4.59% SMA50-8.24% Rel Volume0.73 Prev Close13.27
Employees1616 LT Debt/Eq0.45 EarningsFeb 24 BMO SMA200-1.69% Avg Volume216.04K Price13.38
IPOApr 24, 1992 Option/ShortYes / Yes EPS/Sales Surpr.-2.21% 2.21% Trades Volume158,336 Change0.83%
Date Action Analyst Rating Change Price Target Change
Jan-27-26Initiated TD Cowen Hold $14
Oct-28-25Resumed Stifel Buy $22
Jan-22-25Initiated Canaccord Genuity Buy $24
Nov-08-24Upgrade Stifel Hold → Buy $18 → $24
May-08-24Upgrade ROTH MKM Neutral → Buy $15 → $20
Oct-20-23Initiated ROTH MKM Neutral $12
Sep-12-23Downgrade Stifel Buy → Hold
Sep-12-23Downgrade BTIG Research Buy → Neutral
Jul-19-23Resumed BTIG Research Buy $27
Mar-04-22Upgrade Stifel Hold → Buy $41 → $45
Feb-10-26 07:00AM
Feb-03-26 07:00AM
Jan-09-26 07:00AM
Nov-04-25 04:08PM
08:20AM
07:19AM Loading…
07:19AM
07:00AM
Nov-03-25 07:56AM
Oct-31-25 05:42PM
Oct-15-25 07:00AM
Oct-14-25 07:00AM
Oct-07-25 11:40AM
Oct-03-25 06:49PM
Oct-02-25 10:13AM
Sep-15-25 09:12AM
12:08PM Loading…
Aug-13-25 12:08PM
Aug-07-25 11:40AM
Aug-05-25 08:25AM
07:25AM
07:00AM
Aug-04-25 10:00AM
07:40AM
Jul-16-25 07:00AM
Jul-15-25 07:00AM
Jun-17-25 07:00AM
May-07-25 03:09AM
12:09AM
May-06-25 08:35AM
07:36AM
07:00AM
10:08AM Loading…
May-05-25 10:08AM
Apr-22-25 05:15PM
Apr-18-25 02:06PM
Apr-15-25 08:00AM
Mar-19-25 08:00AM
Mar-12-25 08:00AM
Mar-07-25 07:51AM
Mar-03-25 07:00AM
Feb-26-25 02:18AM
02:07AM
Feb-25-25 08:35AM
07:41AM
07:00AM
01:44AM
Feb-17-25 07:05AM
Jan-28-25 07:00AM
Nov-12-24 07:05AM
Nov-08-24 07:32AM
02:14AM
Nov-07-24 08:25AM
07:23AM
07:05AM
07:05AM
Nov-06-24 07:30AM
Oct-21-24 07:00AM
Oct-10-24 07:00AM
Oct-09-24 12:34PM
Sep-27-24 05:45AM
Sep-23-24 07:00AM
Sep-13-24 05:45AM
Aug-30-24 10:22AM
Aug-15-24 05:52PM
Aug-07-24 06:09AM
Aug-06-24 08:15AM
07:17AM
07:03AM
Jul-17-24 07:00AM
Jul-16-24 07:00AM
Jul-10-24 12:13PM
06:32AM
Jul-09-24 07:00AM
07:00AM
Jun-24-24 07:00AM
03:11AM
Jun-18-24 07:00AM
Jun-11-24 07:00AM
May-23-24 07:00AM
May-16-24 07:15AM
May-13-24 11:18AM
May-09-24 07:00AM
May-08-24 01:03PM
07:43AM
03:16AM
May-07-24 10:38PM
01:53PM
09:34AM
08:21AM
08:00AM
Apr-26-24 06:37AM
Apr-23-24 07:00AM
Apr-16-24 07:00AM
Mar-18-24 07:00AM
Mar-12-24 11:01AM
Mar-07-24 01:40PM
09:53AM
Mar-06-24 08:21AM
Mar-05-24 10:52PM
04:42PM
04:03PM
Feb-29-24 07:00AM
Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Andrews JulieCFOJan 16 '26Sale14.384,87370,07458,039Jan 21 04:09 PM
Calafiore MassimoPresident & CEOJan 09 '26Sale15.829,600151,906227,034Jan 13 05:46 PM
Calafiore MassimoPresident & CEOJan 12 '26Sale15.219,797149,050217,237Jan 13 05:46 PM
Fisher PatrickPresident, Global OrthopedicsAug 18 '25Sale14.211,99628,36330,116Aug 20 04:08 PM
Engine Capital Management, LP10% OwnerJul 02 '25Buy11.111,25013,8813,546,057Jul 07 05:43 PM
McPherron AvivaPres, Global Ops & QualJun 18 '25Sale10.513,72839,18146,322Jun 23 04:15 PM
REINHARDT MAXPresident, Global SpineJun 11 '25Sale11.641,64319,12527,481Jun 13 04:10 PM
Bazaar Alan LeeDirectorJun 04 '25Buy10.922,25024,57030,983Jun 05 05:11 PM
Calafiore MassimoPresident & CEOMay 09 '25Buy12.5410,000125,400234,603May 12 07:14 PM
Bazaar Alan LeeDirectorMay 12 '25Buy12.592,00025,17228,733May 12 04:17 PM
Bazaar Alan LeeDirectorMay 09 '25Buy12.621,99025,12026,733May 12 04:17 PM
Engine Capital Management, LP10% OwnerMay 07 '25Buy12.31100,0001,231,0003,544,807May 08 06:38 PM
Cedron Jorge AndresCLOApr 16 '25Sale13.313,81650,79142,500Apr 18 04:18 PM
Gillespie Geoffrey CCAOApr 02 '25Sale15.74761,19642,445Apr 04 04:23 PM
Vitale LucasCP&BOOMar 18 '25Sale16.604,28771,164135,317Mar 20 04:21 PM
Gillespie Geoffrey CCAOMar 18 '25Sale16.602964,91442,521Mar 20 04:20 PM
Calafiore MassimoPresident & CEOMar 05 '25Buy17.439,914172,801222,404Mar 06 04:27 PM